£109.08

It has never been this cheap. We have no record of a lower price.

£109 today · cheaper than every other day in the last 3 months

Humana PARP Inhibitors for Cancer Therapy (Cancer Drug Discovery and Development)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 72 days · 72 data points (no recent data)

Historical
Generating forecast…
£109.08 £103.63 £105.81 £107.99 £110.17 £112.35 £114.53 01 August 2026 18 August 2026 05 September 2026 23 September 2026 11 October 2026
View at Amazon ↗

Price data last checked 19 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 72 days • 1 price levels

Days at Price
72 days 0 18 36 54 72 £109 Days at Price

Price Analysis

Most common price: £109 (72 days, 100.0%)

Price range: £109 - £109

Price levels: 1 different prices over 72 days

Description

PARP Inhibitors for Cancer Therapy provides a comprehensive overview of the role of PARP in cancer therapy. The volume covers the history of the discovery of PARP (poly ADP ribose polymerase) and its role in DNA repair. In addition, a description of discovery of the PARP family, and other DNA maintenance-associated PARPs will also be discussed. The volume also features a section on accessible chemistry behind the development of inhibitors. PARP inhibitors are a group of pharmacological inhibitors that are a particularly good target for cancer therapy. PARP plays a pivotal role in DNA repair and may contribute to the therapeutic resistance to DNA damaging agents used to treat cancer. Researchers have learned a tremendous amount about the biology of PARP and how tumour-specific defects in DNA repair can be exploited by PARPi. The “synthetic lethality” of PARPi is an exciting concept for cancer therapy and has led to a heightened activity in this area.

Product Specifications

Brand
Humana
Format
paperback
Domain
Amazon UK
Release Date
21 February 2018
Listed Since
20 February 2018

Barcode

No barcode data available

Similar Products You Might Like

Targeting the DNA Damage Response for Anti-Cancer Therapy (Cancer Drug Discovery and Development)
97% match

Targeting the DNA Damage Response for Anti-Cancer Therapy (Cancer Drug Discovery and Development)

Humana

£147.19 12 Oct 2026
Targeting DNA Damage Response for Anti-Cancer Therapy Book
97% match

Targeting DNA Damage Response for Anti-Cancer Therapy Book

Humana

£146.06 08 Oct 2026
Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy
96% match

Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy

Springer

£227.75 15 Oct 2026
Springer Platinum and Metal Coordination Compounds Book
96% match

Springer Platinum and Metal Coordination Compounds Book

Springer

£234.01 15 Oct 2026
Improving the Therapeutic Ratio in Head and Neck Cancer (Volume 6) (Cancer Sensitizing Agents for Chemotherapy, Volume 6)
96% match

Improving the Therapeutic Ratio in Head and Neck Cancer (Volume 6) (Cancer Sensitizing Agents for Chemotherapy, Volume 6)

Elsevier

£117.40 24 Sep 2026
Cancer Biology and Therapeutics
96% match

Cancer Biology and Therapeutics

Springer

£144.84 19 Aug 2026
Cancer Biology and Therapeutics
96% match

Cancer Biology and Therapeutics

Springer

£159.08 19 Sep 2026
Epigenetic Regulation in Overcoming Chemoresistance (Volume 16) (Cancer Sensitizing Agents for Chemotherapy, Volume 16)
96% match

Epigenetic Regulation in Overcoming Chemoresistance (Volume 16) (Cancer Sensitizing Agents for Chemotherapy, Volume 16)

Elsevier

£118.19 06 Oct 2026
Tumor Suppressor Genes in Human Cancer (Cancer Drug Discovery and Development)
96% match

Tumor Suppressor Genes in Human Cancer (Cancer Drug Discovery and Development)

Humana

£34.80 09 Oct 2026
Drug Resistance in Cancer Cells
96% match

Drug Resistance in Cancer Cells

Springer

£111.44 30 Sep 2026
Tumor Suppressor Genes in Human Cancer (Cancer Drug Discovery and Development)
96% match

Tumor Suppressor Genes in Human Cancer (Cancer Drug Discovery and Development)

Humana

£169.76 26 Aug 2026
Overcoming Drug Resistance in Gynecologic Cancers (Volume 17) (Cancer Sensitizing Agents for Chemotherapy, Volume 17)
96% match

Overcoming Drug Resistance in Gynecologic Cancers (Volume 17) (Cancer Sensitizing Agents for Chemotherapy, Volume 17)

Elsevier

£120.98 22 Sep 2026
Small Molecules in Oncology: 211 (Recent Results in Cancer Research, 211)
96% match

Small Molecules in Oncology: 211 (Recent Results in Cancer Research, 211)

Springer

£88.21 02 Oct 2026
Small Molecules in Oncology: 211 (Recent Results in Cancer Research, 211)
96% match

Small Molecules in Oncology: 211 (Recent Results in Cancer Research, 211)

Springer

£84.17 01 Oct 2026
Combination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development)
96% match

Combination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development)

Humana

£80.67 18 Sep 2026
Anthracycline Chemistry and Biology I: Biological Occurence and Biosynthesis, Synthesis and Chemistry: 282 (Topics in Current Chemistry, 282)
96% match

Anthracycline Chemistry and Biology I: Biological Occurence and Biosynthesis, Synthesis and Chemistry: 282 (Topics in Current Chemistry, 282)

Springer

£111.24 23 Aug 2026
Animal Models in Cancer Drug Discovery
96% match

Animal Models in Cancer Drug Discovery

Elsevier

£115.37 30 Sep 2026
Combination Cancer Therapy: Modulators and Potentiators Guide
96% match

Combination Cancer Therapy: Modulators and Potentiators Guide

Humana

£42.21 06 Oct 2026
Cancer Drug Resistance: Overviews and Methods: 1395 (Methods in Molecular Biology, 1395)
96% match

Cancer Drug Resistance: Overviews and Methods: 1395 (Methods in Molecular Biology, 1395)

Humana

£88.21 12 Sep 2026
Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response (Cancer Drug Discovery and Development)
96% match

Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response (Cancer Drug Discovery and Development)

Humana

£27.79 21 Aug 2026
Chemistry and Pharmacology of Anticancer Drugs - CRC Press
96% match

Chemistry and Pharmacology of Anticancer Drugs - CRC Press

CRC Press

£126.97 02 Oct 2026
Chemistry and Pharmacology of Anticancer Drugs
96% match

Chemistry and Pharmacology of Anticancer Drugs

CRC Press

£205.87 02 Oct 2026
Mutant p53 and MDM2 in Cancer: 85 (Subcellular Biochemistry, 85)
96% match

Mutant p53 and MDM2 in Cancer: 85 (Subcellular Biochemistry, 85)

Springer

£91.47 05 Oct 2026
Mutant p53 and MDM2 in Cancer - Subcellular Biochemistry Vol. 85
96% match

Mutant p53 and MDM2 in Cancer - Subcellular Biochemistry Vol. 85

Springer

£108.01 08 Oct 2026